Waters Corporation’s (NYSE:WAT) Q3 2026 sales beat estimates, quarterly revenue guidance slightly exceeds expectations
Waters Corporation (NYSE:WAT) reported Q3 2026 revenue of $1.77B, exceeding estimates by 0.7% and growing 121% YoY. Adjusted EPS was $4.10, a 2.6% beat. Q4 guidance was raised to $1.81B in revenue and $14.65 in adjusted EPS. Operating and free cash flow margins declined YoY, while organic revenue rose 9%.
How this was made
The 30-second read
Why it matters
The combination of earnings beats and modest guidance increases is supportive, but the steep year-over-year drop in operating margin and free-cash-flow margin is a key risk to follow-through.
Market read
This is a company-specific earnings and guidance update with enough detail (beats plus guidance midpoints and margin/FCF deterioration) to drive near-term repricing and analyst model updates.
What to watch
Margin and FCF margin declines are large in the article; traders may focus on whether this is temporary (cost normalization) or structural (pricing pressure, mix shift, or higher expenses).
Background
The piece summarizes Waters’ Q3 2026 results versus S&P analysts’ consensus and provides Q4 2026 revenue and EPS guidance, including a slight full-year EPS guidance raise.
Ticker impact
Waters reported Q3 revenue of $1.77B vs $1.75B consensus and raised Q4 revenue guidance to $1.81B midpoint, slightly above expectations.
Likely upward bias as the market prices in the guidance beat, offset by caution from sharply lower operating and free-cash-flow margins.
The article contains fresh, company-specific earnings and guidance numbers (revenue, EPS, Q4 midpoint guidance, and full-year EPS guidance) plus explicit margin and FCF margin declines, which typically drive a mixed but net-positive reaction.
Market effects
Signals continued demand strength in life-science tools while highlighting cost/operating leverage pressure that can influence sentiment across instrumentation peers.
Primarily US large-cap sentiment; limited direct regional spillover beyond the specialty instruments group.
Moderate, as Waters is a global supplier and guidance can affect expectations for lab spending, but no cross-border policy or supply shock is cited.
Counterpoint
The guidance raise is only slight, while operating margin and free-cash-flow margin collapse versus last year, suggesting the beat may be less about durable improvement and more about timing or mix.
Key entities
- companyWaters Corporation
Reported Q3 revenue and adjusted EPS beats, raised Q4 revenue guidance, and slightly increased full-year adjusted EPS guidance, while margins and FCF margin declined sharply year over year.
